Lancet: The clinical stage IIb results of the third antibody sonelokimab are excellent. On April 23, Lancet published online detailed...
Drugs
Keytruda(Pembrolizumab): The hope of patients with esophageal cancer may also be the hope of other cancer patients. On...
PNAS: ICOS and IL-10 act synergistically to promote the host-microbial community. Genome-wide Association Study (GWAS) results show that:...
Which company will win the competition of RSV therapy? Which company will win the competition of RSV therapy? Respiratory...
Precision screening tool for immunotherapy: Molecular immunoPET imaging technology Screening tool for immunotherapy: Molecular immunoPET imaging technology. Immunotherapy can...
New oral drug: Dextromethorphan/Bupropion for Major Depression (MDD) New oral drug: Dextromethorphan/Bupropion for Major Depression (MDD). The new oral...
Exosomes and obesity-related insulin resistance Exosomes and obesity-related insulin resistance. Obesity is very important for the development of insulin resistance....
FDA accelerates approval of GSK's new endometrial cancer drug: Jemperli FDA accelerates approval of GSK's new endometrial cancer drug: Jemperli. ...
Keytruda+Lenvima: "Immune + Targeted" treatment of uterine body cancer! Keytruda+Lenvima: "Immune + Targeted" treatment of uterine body cancer! The...
2021 New Antibody drug: Loncastuximab tesirine-lpyl (Zynlonta) 2021 New Antibody drug: Loncastuximab tesirine-lpyl (Zynlonta). On April 23, 2021, the...
Understand the treatment methods of Nanobodies Understand the treatment methods of Nanobodies. "Cell" magazine (Cell) published an important paper...
Many mRNA medicines other than mRNA coronavirus vaccine Many mRNA medicines other than mRNA coronavirus vaccine. Previously, it was...
2021 New antibody drugs: Dostarlimab-gxly 2021 New antibody drugs: Dostarlimab-gxly. Dostarlimab is a humanized anti-PD-1 monoclonal antibody that binds...
Roche IL-6R monoclonal antibody Enspryng is about to be approved in EU Roche IL-6R monoclonal antibody Enspryng is about...
Padcev: Bladder cancer is expected to usher in new therapies. Padcev: Bladder cancer is expected to usher in...
Pembrolizumab treats advanced lung squamous cell carcinoma Pembrolizumab treats advanced lung squamous cell carcinoma. Pembrolizumab completely breaks through the...
How to reduce gastrointestinal bleeding caused by Aspirin? How to reduce gastrointestinal bleeding caused by Aspirin? Aspirin has made...
Diffuse large B-cell lymphoma (DLBCL): Lenzilumab plus CAR-T cell therapy 100% effective DLBCL: Lenzilumab combined with CAR-T cell therapy...
Lung cancer: Cimeprizumab (Drug C) has a powerful single-agent treatment effect Lung cancer: Cimeprizumab (Drug C) has a powerful...
Linker strategy in bispecific antibody technology platform Linker strategy in bispecific antibody technology platform. The most important point of...
First drug for Childhood achondroplasia is expected to come soon First drug for Childhood achondroplasia is expected to come...
Gastric cancer: Amgen’s FGFR2b targeted monoclonal antibody bemarituzumab Innovative therapy for gastric cancer: Amgen’s FGFR2b targeted monoclonal antibody bemarituzumab...
The most common overdose drug in the world: APAP The most common overdose drug in the world: APAP. Acetaminophen (Paracetamol,...
Latest research progress of allogeneic CAR-T cell therapy Latest research progress of allogeneic CAR-T cell therapy. In recent decades,...
Eli Lilly Coronavirus Antibody Bamlanivimab was revoked by FDA Eli Lilly Coronavirus Antibody Bamlanivimab was revoked by FDA. Burst!...
Bispecific antibodies: on-target off-tumor Toxicity and Overcoming strategies Bispecific antibodies: on-target off-tumor Toxicity and Overcoming strategies. CD3XTAAs...
The difference between Amoxicillin and Cephalosporins Israel new drug for COVID-19: EXO-CD24 can reduce deaths by 50% COVID-19 vaccines for...
Three options for making chimeric antigen receptor T cells Three options for making chimeric antigen receptor T cells. A...
COVID-19: EU began to review GSK/Vir monoclonal antibody VIR-7831 EU began to review GSK/Vir monoclonal antibody VIR-7831: early treatment...
Viral vector-based therapeutic drugs for genetic diseases Viral vector-based therapeutic drugs for genetic diseases. Gene medicine is one of...